These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 1533604

  • 1. Growth, bone maturation and height prediction after three years of therapy with the slow release GnRH-agonist Decapeptyl-Depot in children with central precocious puberty.
    Hümmelink R, Oostdijk W, Partsch CJ, Odink RJ, Drop SL, Sippell WG.
    Horm Metab Res; 1992 Mar; 24(3):122-6. PubMed ID: 1533604
    [Abstract] [Full Text] [Related]

  • 2. [Growth, development and prediction of body height in children with central precocious puberty after 3 years of therapy with Decapeptyl-Depot, a slow-releasing GnRH agonist].
    Hümmelink R, Oostdijk W, Partsch CJ, Odink RJ, Drop SL, Sippell WG.
    Cesk Pediatr; 1994 Mar; 49(1):7-12. PubMed ID: 8124755
    [Abstract] [Full Text] [Related]

  • 3. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone release hormone (D-Tryp6-GnRH) in monthly injections. Its possible use in normal puberty.
    Marcondes JA, Abujamra AC, Minanni SL, Mendonca BB, Nery M, Lerario AC, Pereira MA, Abelin N, Wajchenberg BL.
    Horm Metab Res; 1993 Feb; 25(2):105-9. PubMed ID: 8458605
    [Abstract] [Full Text] [Related]

  • 4. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
    Mansfield MJ, Beardsworth DE, Loughlin JS, Crawford JD, Bode HH, Rivier J, Vale W, Kushner DC, Crigler JF, Crowley WF.
    N Engl J Med; 1983 Nov 24; 309(21):1286-90. PubMed ID: 6415479
    [Abstract] [Full Text] [Related]

  • 5. [Long-term therapy with delayed-action LHRH-antagonist decapeptyl depot in girls with precocious puberty. Results of an international multicenter study].
    Sippell WG, Partsch CJ, Hümmelink R, Lorenzen F.
    Gynakologe; 1991 Apr 24; 24(2):108-13. PubMed ID: 1835952
    [No Abstract] [Full Text] [Related]

  • 6. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
    Léger J, Reynaud R, Czernichow P.
    J Pediatr; 2000 Dec 24; 137(6):819-25. PubMed ID: 11113839
    [Abstract] [Full Text] [Related]

  • 7. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. The German-Dutch Precocious Puberty Study Group.
    Partsch CJ, Hümmelink R, Peter M, Sippell WG, Oostdijk W, Odink RJ, Drop SL.
    Horm Res; 1993 Dec 24; 39(3-4):111-7. PubMed ID: 8262471
    [Abstract] [Full Text] [Related]

  • 8. Long-term results with a slow-release gonadotrophin-releasing hormone agonist in central precocious puberty. Dutch-German Precocious Puberty Study Group.
    Oostdijk W, Drop SL, Odink RJ, Hümmelink R, Partsch CJ, Sippell WG.
    Acta Paediatr Scand Suppl; 1991 Dec 24; 372():39-45; discussion 46. PubMed ID: 1833950
    [Abstract] [Full Text] [Related]

  • 9. Body mass index and body composition in adolescents treated with gonadotropin-releasing hormone analogue triptorelin depot for central precocious puberty: data at near final height.
    Chiocca E, Dati E, Baroncelli GI, Mora S, Parrini D, Erba P, Bertelloni S.
    Neuroendocrinology; 2009 Dec 24; 89(4):441-7. PubMed ID: 19176945
    [Abstract] [Full Text] [Related]

  • 10. Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty.
    Bajpai A, Sharma J, Kabra M, Gupta AK, Menon PS.
    Indian Pediatr; 2002 Jul 24; 39(7):633-9. PubMed ID: 12147888
    [Abstract] [Full Text] [Related]

  • 11. The histrelin implant: a novel treatment for central precocious puberty.
    Hirsch HJ, Gillis D, Strich D, Chertin B, Farkas A, Lindenberg T, Gelber H, Spitz IM.
    Pediatrics; 2005 Dec 24; 116(6):e798-802. PubMed ID: 16322137
    [Abstract] [Full Text] [Related]

  • 12. [Comparison between complete and incomplete suppression of the hypophyseal-gonadal axis in girls with central precocious puberty: effect on growth and prospective final height].
    Partsch CJ, Hümmelink R, Sippell WG, Oostdijk W, Odink RJ, Drop SL.
    Monatsschr Kinderheilkd; 1993 Dec 24; 141(12):935-9. PubMed ID: 8114776
    [Abstract] [Full Text] [Related]

  • 13. Precocious puberty and statural growth.
    Carel JC, Lahlou N, Roger M, Chaussain JL.
    Hum Reprod Update; 2004 Dec 24; 10(2):135-47. PubMed ID: 15073143
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of central precocious puberty with an LHRH analog. Effect on growth and bone maturation after 2 years of treatment].
    Brauner R, Rappaport R.
    Arch Fr Pediatr; 1987 Apr 24; 44(4):271-6. PubMed ID: 3109347
    [Abstract] [Full Text] [Related]

  • 15. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF, McNeill E, Young D, Donaldson MD.
    Clin Endocrinol (Oxf); 2004 Nov 24; 61(5):626-34. PubMed ID: 15521967
    [Abstract] [Full Text] [Related]

  • 16. [Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty].
    Liang Y, Wei H, Zhang JL, Hou L, Luo XP.
    Zhonghua Er Ke Za Zhi; 2004 Nov 24; 42(11):845-9. PubMed ID: 15631714
    [Abstract] [Full Text] [Related]

  • 17. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
    Poomthavorn P, Suphasit R, Mahachoklertwattana P.
    Gynecol Endocrinol; 2011 Aug 24; 27(8):524-8. PubMed ID: 21501002
    [Abstract] [Full Text] [Related]

  • 18. Treatment of children with central precocious puberty by a slow-release gonadotropin-releasing hormone agonist.
    Oostdijk W, Hümmelink R, Odink RJ, Partsch CJ, Drop SL, Lorenzen F, Sippell WG, van der Velde EA, Schultheiss H.
    Eur J Pediatr; 1990 Feb 24; 149(5):308-13. PubMed ID: 2138079
    [Abstract] [Full Text] [Related]

  • 19. Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious Puberty.
    Carel JC, Roger M, Ispas S, Tondu F, Lahlou N, Blumberg J, Chaussain JL.
    J Clin Endocrinol Metab; 1999 Jun 24; 84(6):1973-8. PubMed ID: 10372696
    [Abstract] [Full Text] [Related]

  • 20. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
    Lanes R, Soros A, Jakubowicz S.
    J Pediatr Endocrinol Metab; 2004 May 24; 17(5):759-66. PubMed ID: 15237711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.